# EGFR CART Cells for Patients With Metastatic Colorectal Cancer

> **NCT03152435** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shenzhen Second People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- EGFR-positive Colorectal Cancer

## Interventions

- **BIOLOGICAL:** EGFR CART

## Key facts

- **NCT ID:** NCT03152435
- **Lead sponsor:** Shenzhen Second People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-15
- **Primary completion:** 2019-09
- **Final completion:** 2019-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152435, "EGFR CART Cells for Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03152435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*